Biogen Inc (NASDAQ:BIIB)

291.87
Delayed Data
As of Feb 16
 -7.51 / -2.51%
Today’s Change
244.28
Today|||52-Week Range
370.57
-8.38%
Year-to-Date
Acorda (ACOR) Q4 Earnings Miss Estimates, Revenues Beat
Feb 16 / Zacks.com - Paid Partner Content
Richard Pzena's Top 5 New Buys of the 4th Quarter
Feb 12 / GuruFocus News - Paid Partner Content
FDA Sets the Stage for Earlier-Stage Alzheimer's Treatments
Feb 16 / Zacks.com - Paid Partner Content
3 ETFs to Watch on Biotech Earnings
Feb 10 / Zacks.com - Paid Partner Content
Sentinel Trust Co Lba Buys iShares Core MSCI EAFE, iShares Russell 3000, Facebook Inc...
Feb 15 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Novartis, BP and Biogen
Feb 09 / Zacks.com - Paid Partner Content
Alkermes (ALKS) Beats Q4 Earnings, Revenue Estimates
Feb 15 / Zacks.com - Paid Partner Content
Top Research Reports for Novartis, BP & Biogen
Feb 08 / Zacks.com - Paid Partner Content
Merck (MRK) Halts Another Late Stage Study on Alzheimer's
Feb 14 / Zacks.com - Paid Partner Content
Biogen Halts Tysabri Development in Stroke as Study Fails
Feb 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close299.38
Today’s open297.75
Day’s range290.88 - 298.50
Volume2,943,057
Average volume (3 months)1,357,076
Market cap$61.7B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-29.56%
Earnings growth (this year)+13.87%
Earnings growth (next 5 years)+4.47%
Revenue growth (last year)+7.81%
P/E ratio24.5
Price/Sales6.17
Price/Book4.89

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+0.07+0.03%
GILDGilead Sciences-0.85-1.04%
----
BIVVBioverativ Inc+0.07+0.07%
Data as of 4:15pm ET, 02/16/2018

Financials

Next reporting dateApril 26, 2018
EPS forecast (this quarter)$5.92
Annual revenue (last year)$11.0B
Annual profit (last year)$2.5B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Senior Vice President-
US Therapeutic Operations
Alisha A. Alaimo
Corporate headquarters
Cambridge, Massachusetts

Forecasts